Morgan E. Grams

2 months ago | nature.com | Morgan E. Grams

AbstractThe timely and rational institution of therapy is a key step towards reducing the global burden of chronic kidney disease (CKD). CKD is a heterogeneous entity with varied aetiologies and diverse trajectories, which include risk of kidney failure but also cardiovascular events and death. Developments in the past decade include substantial progress in CKD risk prediction, driven in part by the accumulation of electronic health records data.

2 months ago | jamanetwork.com | Tao Huang |Alessandro Bosi |Anne-Laure Faucon |Morgan E. Grams

Error in Figure and Results GLP-1RA vs DPP-4i Use and Hyperkalemia and RAS Blockade Discontinuation Tao Huang, MSc; Alessandro Bosi, MSc; Anne-Laure Faucon, MD, PhD; Morgan E. Grams, MD, PhD; Arvid Sjölander, PhD; Edouard L.

Aug 12, 2024 | jamanetwork.com | Tao Huang |Alessandro Bosi |Morgan E. Grams

Key PointsQuestion  Is the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) vs dipeptidyl peptidase-4 inhibitors (DPP-4is) associated with different rates of hyperkalemia or prolonged renin-angiotensin system (RAS) inhibitor use in people with type 2 diabetes (T2D)? Findings  In this cohort study of 33 280 patients with T2D, the use of GLP-1RAs was associated with a lower rate of hyperkalemia and prolonged RAS inhibitor use compared with the use of DPP-4is.

Dec 5, 2023 | bmj.com | Teresa Chen |Melanie P. Hoenig |Dorothea Nitsch |Morgan E. Grams

Teresa K Chen, assistant professor1, Melanie P Hoenig, associate professor2, Dorothea Nitsch, professor3, Morgan E Grams, professor4 1Kidney Health Research Collaborative and Division of Nephrology, Department of Medicine, University of California San Francisco; and San Francisco VA Health Care System, San Francisco, CA, USA 2Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA 3Department of Non-Communicable Disease...

Oct 3, 2023 | jamanetwork.com | Lawrence J. Appel |Morgan E. Grams |Mark Woodward |Katie Harris

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis Reported Awareness and Adoption of 2021 eGFR Equations Among US Clinical Laboratories, March 2022 Jonathan R. Genzen, MD, PhD; Rhona J. Souers, MS; Lauren N. Pearson, DO, MPH; David M. Manthei, MD, PhD; Allison B. Chambliss, PhD; Zahra Shajani-Yi, PhD; W.